New Delhi, March 27 AAP MP Vikramjit Singh Sahney raised the issue of spurious medicines on Friday and expressed serious concerns about the growing threat of substandard and counterfeit medicines in the country.During the zero hour in the Rajya Sabha, he said the issue of manufacturing...
cdsco
central drugs standard control organisation
counterfeit medicines
drug quality standards
drug regulation
drug safety
himachal pradesh
india
medicine samples
paracetamol
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical quality
spurious medicines
uttarakhand
New Delhi, March 26 The National Medical Commission (NMC) has issued an advisory declaring stem cell therapy illegal for the treatment of Autism Spectrum Disorder in compliance with a Supreme Court order.The move is aimed at curbing illegal practices by private clinics in metropolitan and...
autism spectrum disorder
cdsco
central drugs standard control organisation
clinical trials
department of health research
dhr
ethical guidelines
icmr
indian council of medical research
medical advisory
medical practice
national medical commission
nmc
regulatory compliance
stem cell therapy
supreme court
New Delhi, March 20 The Central Drug Laboratories have found 60 drug samples manufactured by various firms to be "not of standard quality (NSQ)" in its monthly drug alert for February, health ministry officials said on Friday.The state drug testing laboratories have identified 134 drug samples...
assam
cdsco
central drug laboratories
delhi
drug quality
drug quality control
drug regulation
drug samples
drug surveillance
drug testing
ghaziabad
not of standard quality (nsq)
pharmaceuticals
regulatory compliance
spurious drugs
state drug testing laboratories
New Delhi, March 20 Eris Lifesciences launched a generic version of Semaglutide under the brand name 'Sundae' in the country on Friday, capitalizing on the expiration of patents for molecules similar to Ozempic and Wegovy in India.The company stated that it is introducing the diabetes and...
New Delhi, March 19 The Central Drugs Standard Control Organisation (CDSCO) has issued comprehensive guidelines outlining a dossier-based approach for issuing and renewing drug manufacturing licenses, aimed at ensuring uniform product licensing and quality standards.The document, released last...
cdsco
central drugs standard control organisation
dossier-based licensing
drug licensing
drug regulatory authorities
drugs and cosmetics act
firm-facility details
india pharmaceutical sector
licensing requirements
pharmaceutical compliance
pharmaceutical manufacturing
pharmaceutical quality standards
product-specific data
regulatory evaluation
regulatory guidelines
New Delhi, February 17 The apex drug regulator, CDSCO, has approved three drugs – Orlistat, Tirzepatide, and Semaglutide – for weight loss treatment in the country, which can be sold in retail with a doctor's prescription, Minister of State for Health, Anupriya Patel, said on Tuesday.All drugs...
New Delhi, March 17 – The Delhi High Court issued a notice on Tuesday regarding a contempt petition alleging non-compliance with its earlier order directing the Central Drugs Standard Control Organisation (CDSCO) to examine safety and regulatory concerns regarding the use of certain diabetes...
cdsco
central drugs standard control organisation
contempt petition
dcgi
delhi high court
diabetes drugs
drugs controller general of india
glp-1 receptor agonists
judicial directions
legal proceedings
new drugs and clinical trials rules
pharmacovigilance
regulatory compliance
union health secretary
weight loss
New Delhi, March 11 The apex drug regulator, CDSCO, has issued an advisory, directing that weight-loss drugs, specifically GLP-1 medications, must only be sold with a prescription from a registered medical practitioner.It cautioned pharmaceutical companies against "directly or indirectly"...
New Delhi, March 10 The Union Health Ministry has launched the Strategy for AI in Healthcare in India (SAHI) and the Benchmarking Open Data Platform for Health AI (BODH) to promote the secure and evidence-based deployment of artificial intelligence in the country's healthcare ecosystem, the...
artificial intelligence
ayushman bharat digital mission
benchmarking
cdsco
data standards
digital health
government initiatives
healthcare
iit kanpur
india
medical devices
regulatory compliance
technology
New Delhi, February 25 In a move aimed at speeding up approvals for new drugs, the government has changed the way testing permissions are granted, allowing companies to begin laboratory testing immediately after filing applications instead of waiting for detailed scrutiny.In an official...
cdsco
central drugs standard control organization
drug approval process
drug samples
drug testing
drugs and cosmetics act
ghaziabad
indian pharmacopoeia commission
kasauli
laboratory testing
mumbai
noida
pharmacopoeia
quality management system
regulatory approvals
regulatory specifications
India and Brazil have exchanged a Memorandum of Understanding (MoU) to strengthen bilateral cooperation in the regulation of pharmaceutical and medical products. In a statement, the Ministry of Health and Family Welfare informed that the MoU was exchanged between India's Central Drugs Standard...
anvisa
bilateral cooperation
brazil
cdsco
dinesh bhatia
health regulation
india
leandro safatle
luiz inácio lula da silva
medical products
memorandum of understanding
narendra modi
new delhi
pharmaceutical regulation
regulatory affairs
New Delhi, February 16 Contaminated nutritional supplements, misuse of prescription medicines, and the online sale of prohibited substances were among the major points of discussion at the fourth National Compliance Platform meeting, which took place here on Monday to discuss emerging issues...
anti-doping initiatives
cdsco
central drugs standard control organisation
doping in sports
food safety and standards authority of india
fssai
nada
narcotics control bureau
national anti-doping agency
national compliance platform
ncb
prescription medicines
prohibited substances
sports supplements
supply chain monitoring